Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company headquartered in Cupertino, California, dedicated to addressing unmet medical needs through the development of innovative therapies targeting central nervous system, cardiovascular, metabolic, and inflammatory disorders. With a strong emphasis on a differentiated drug development approach, Reviva aims to deliver safe and effective treatments that enhance patient outcomes. The company is strategically positioned to leverage its robust pipeline and capitalize on growth opportunities in the dynamic pharmaceutical sector, making it an attractive prospect for institutional investors seeking to partner with a forward-thinking organization in the biopharmaceutical industry.